Clinical use of biomarkers in neurodegenerative disorders

The prevalence of neurodegenerative disorders is increasing dramatically and one of the major challenges today is the need of early and accurate diagnosis, the other is the need of more effective therapies -in turn the development of such therapies also requires early and accurate diagnosis-. The ma...

Descripció completa

Dades bibliogràfiques

Autor principal:	Manuel Menendez-Gonzalez
Format:	Online
Idioma:	anglès
Publicat:	Frontiers Media SA 2021
Matèries:	RC321-571 Q1-390 Neurodegenerative Diseases neurodegenerative disease Parkinson's disease MTAi biomarker Huntington's disease CSF biomarkers Frontotemporal dementia (FTD) thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Accés en línia:	17793
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!